InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Reicin Alise, 首席执行官. Insider active across 1 company, notably Tectonic Therapeutic, Inc.. In total, 10 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €89k. History available since 4 December 2024. The latest transaction was filed on 4 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Reicin Alise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
76,500 股0Common StockSEC:0001757533-26-000009:0
2,500 股@ US$21.100.0084% mcap50.0% 占其流量Common StockSEC:0001757533-26-000008:0
标准退出：2026年5月12日 (T+90)
2,500 股@ US$21.1021.5% 占其流量Common StockSEC:0001757533-26-000005:0
标准退出：2026年5月12日 (T+90)
4,104 股@ US$23.2239.1% 占其流量Common StockSEC:0001757533-26-000004:0
10,966 股@ US$2.3810.8% 占其流量Common StockSEC:0001757533-26-000002:0
14,700 股0Common StockSEC:0001757533-25-000004:0
859 股@ US$19.8125.0% 占其流量Common StockSEC:0001415889-25-018106:0
36,047 股0Common StockSEC:0001415889-25-003225:0
11,717 股0Common StockSEC:0001415889-24-028516:0
166,580 股Common StockSEC:0001415889-24-017952:0
10 条申报中的 10 条
About Reicin Alise
Alise Reicin is the Chief Executive Officer of Tectonic Therapeutic, Inc. She oversees the strategic and operational direction of the company, ensuring it achieves its growth objectives. Reicin brings extensive experience in the biopharmaceutical sector.
